Login
$AARD
$0.98 -$0.41 (29.85%) Live

Ownership

13F as of Q2 2026 · 21.9M shares outstanding

Who owns AARD?

By type of holder
Institutions 43.0% Insiders 5.5% Everyone else 51.5%
Concentration Top 10 holders own 39.6%
Decheng Capital LLC 17.9% · Citadel Advisors LLC 5.9%
Institutional ownership
43.0%
-3.6 pts vs last qtr
Institutional holders
70
-9 vs last qtr
Net shares bought
−792.9K
by institutions in Q2 2026
New / sold out
17 / 26
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • EcoR1 Capital, LLC NEW +396.2K
  • Aqr Capital Management LLC +345.8K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BlackRock, Inc. −605.5K
  • Tetragon Partners GP Ltd SOLD OUT −316.6K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$381K
2 notices from 1 person
Shares covered
76.8K
0.35% of the company
Arranged in advance
100%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$190.3K$380.7KNovDecJanFebMarAprMayJunJulAugSep 2026: $380.7K under a 10b5-1 planSepOct
Largest proposed sellers
  • Nelson Sun Officer 10b5-1 $381K
Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2024–FY2025
+391.1%
+391.06% a year
Each share's claim on the business
−79.6%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $4.39M
over 2 fiscal years
Diluted shares, split-adjusted
457.4K1.4M2.3M2024: 471.6K shares'242025: 2.3M shares'25
Buybacks Stock-based comp
$0$2.0M$3.9M2024 buybacks: $02024 stock comp: $439.0K'242025 buybacks: $02025 stock comp: $3.9M'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years80% Under 1 year20%
Quarterly turnover
15.3%
of institutional shares changed hands
Top 10 managers, median time held
1.3 years

Super Investors

Investment managers reporting AARD on Form 13F
DC
Decheng Capital LLC
Shares
3.9M
% of company
17.90%
Change vs last qtr
Unchanged
Held since
2025
CA
Citadel Advisors LLC
Shares
1.3M
% of company
5.86%
Change vs last qtr
+40.4K (+3.2%)
Held since
2025

28 more super investors behind a free account

See every manager holding Aardvark Therapeutics, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting AARD on Form N-PORT; together they hold 7.5% of the company
VT
Position value
$2.35M
% of company
1.87%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$1.15M
% of company
1.40%
% of the fund
0.00%
As of
March 31, 2026

23 more funds behind a free account

See every fund holding Aardvark Therapeutics, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
LT
Lee Tien-Li
Insider
Shares
357.0K
% of company
1.63%
Change vs last qtr
—
Held since
—
VV
Vickers Venture Fund VI Pte Ltd
Insider
Shares
242.0K
% of company
1.11%
Change vs last qtr
—
Held since
—

3 more holders behind a free account

See every insider and 5%+ holder of Aardvark Therapeutics, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support